UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

S1PR5 is essential for human natural killer cell migration toward sphingosine-1 phosphate

Journal of allergy and clinical immunology, 2018-06, Vol.141 (6), p.2265-2268.e1

2018

Volltextzugriff (PDF)

Novel Potent Selective Orally Active S1P5 Receptor Antagonists

ACS medicinal chemistry letters, 2021-03, Vol.12 (3), p.351-355

2021

Volltextzugriff (PDF)

Isolation of Microglia and Analysis of Protein Expression by Flow Cytometry: Avoiding the Pitfall of Microglia Background Autofluorescence

Bio-protocol, 2021-07, Vol.11 (14), p.e4091-e4091

2021

Volltextzugriff (PDF)

Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation

Journal of allergy and clinical immunology, 2016-06, Vol.137 (6), p.1809-1821.e12

2016

Volltextzugriff (PDF)

Gene expression alterations in salivary gland epithelia of Sjögren's syndrome patients are associated with clinical and histopathological manifestations

Scientific reports, 2021-05, Vol.11 (1), p.11154-11154, Article 11154

2021

Volltextzugriff (PDF)

Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome

European journal of immunology, 2020-01, Vol.50 (1), p.119-129

2020

Volltextzugriff (PDF)

RNA-Seq and CyTOF immuno-profiling of regenerating lacrimal glands identifies a novel subset of cells expressing muscle-related proteins

PloS one, 2017-06, Vol.12 (6), p.e0179385-e0179385

2017

Volltextzugriff (PDF)

Organotypic Brain Slice Culture Microglia Exhibit Molecular Similarity to Acutely-Isolated Adult Microglia and Provide a Platform to Study Neuroinflammation

Frontiers in cellular neuroscience, 2020-12, Vol.14, p.592005-592005

2020

Volltextzugriff (PDF)

Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis

Journal of neuroinflammation, 2022-12, Vol.19 (1), p.306-306, Article 306

2022

Volltextzugriff (PDF)

Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis

iScience, 2023-01, Vol.26 (1), p.105785-105785, Article 105785

2023

Volltextzugriff (PDF)

The proline-rich sequence of CD3ε controls T cell antigen receptor expression on and signaling potency in preselection CD4+CD8+ thymocytes

Nature immunology, 2008-05, Vol.9 (5), p.522-532

2008

Volltextzugriff (PDF)

Conditional density-based analysis of T cell signaling in single-cell data

Science (American Association for the Advancement of Science), 2014-11, Vol.346 (6213), p.1079-1079

2014

Volltextzugriff (PDF)

Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3

Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (48), p.14942-14947

2015

Volltextzugriff (PDF)

BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy

Acta neuropathologica, 2022-04, Vol.143 (4), p.505-521

2022

Volltextzugriff (PDF)

Interleukin‐7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren’s Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2021-04, Vol.73 (4), p.631-640

2021

Volltextzugriff (PDF)

MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response

Brain (London, England : 1878), 2021-09, Vol.144 (8), p.2361-2374

2021

Volltextzugriff (PDF)

Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors

Bioorganic & medicinal chemistry letters, 2022-03, Vol.60, p.128549-128549, Article 128549

2022

Volltextzugriff (PDF)

Variability of Primary Sjögren's Syndrome Is Driven by Interferon‐α and Interferon‐α Blood Levels Are Associated With the Class II HLA–DQ Locus

Arthritis & rheumatology (Hoboken, N.J.), 2022-12, Vol.74 (12), p.1991-2002

2022

Volltextzugriff (PDF)

Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model

The Journal of immunology (1950), 2022-04, Vol.208 (7), p.1566-1584

2022

Volltextzugriff (PDF)

Corrigendum to “Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors” [Bioorg. Med. Chem. Lett. 60 (2022) 128549]

Bioorganic & medicinal chemistry letters, 2022-09, Vol.72, p.128856-128856, Article 128856

2022

Volltextzugriff (PDF)

Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome

Rheumatology (Oxford, England), 2017-02, Vol.56 (2), p.303-312

2017

Volltextzugriff (PDF)

Role of the IL-12/IL-35 balance in patients with Sjögren syndrome

Journal of allergy and clinical immunology, 2018-07, Vol.142 (1), p.258-268.e5

2018

Volltextzugriff (PDF)

Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis

Journal of medicinal chemistry, 2024-05, Vol.67 (10), p.8122-8140

2024

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaMice, Inbred C57bl

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)

Publikationsform

Artikel
(41)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

S1PR5 is essential for human natural killer cell migration toward sphingosine-1 phosphate

Novel Potent Selective Orally Active S1P5 Receptor Antagonists

Isolation of Microglia and Analysis of Protein Expression by Flow Cytometry: Avoiding the Pitfall of Microglia Background Autofluorescence

Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation

Gene expression alterations in salivary gland epithelia of Sjögren's syndrome patients are associated with clinical and histopathological manifestations

Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome

RNA-Seq and CyTOF immuno-profiling of regenerating lacrimal glands identifies a novel subset of cells expressing muscle-related proteins

Organotypic Brain Slice Culture Microglia Exhibit Molecular Similarity to Acutely-Isolated Adult Microglia and Provide a Platform to Study Neuroinflammation

Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis

Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis

The proline-rich sequence of CD3ε controls T cell antigen receptor expression on and signaling potency in preselection CD4+CD8+ thymocytes

Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells

Conditional density-based analysis of T cell signaling in single-cell data

Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3

BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy

Interleukin‐7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren’s Syndrome

MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response

Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors

Variability of Primary Sjögren's Syndrome Is Driven by Interferon‐α and Interferon‐α Blood Levels Are Associated With the Class II HLA–DQ Locus

Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model

Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis

Corrigendum to “Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors” [Bioorg. Med. Chem. Lett. 60 (2022) 128549]

Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome

Role of the IL-12/IL-35 balance in patients with Sjögren syndrome

Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis

Aktive Filter

Suchergebnisse filtern